Medication adherence in type 2 diabetes patients: study of patients in Alimosho General Hospital, Igando, Lagos, Nigeria. by Awodele, O & Osuolale, JA
Medication adherence in type 2 diabetes patients: study of  patients 
in Alimosho General Hospital, Igando, Lagos, Nigeria. 
Olufunsho Awodele1, Jemeela  A. Osuolale2
1.  Department of  Pharmacology, Therapeutics & Toxicology, College of  Medicine, 
     PMB 12003, Idi Araba, University of  Lagos, Lagos-Nigeria
2.  Department of  Pharmacy, Alimosho General Hospital, Igando, Lagos-Nigeria
Abstract
Background: Poor adherence is an obstacle in therapeutic control of  diabetes. Despite the advances in the treatment of  
diabetes mellitus over the years, diabetes places an immense burden on the individuals living with the condition, their families 
and the overall health care system.
Objective: Evaluation of  the impact of  medication adherence on the clinical outcomes of  type 2 diabetes patients at Ali-
mosho general hospital, Igando Lagos state.
Method: The medication adherence study was both descriptive (retrospective) and prospective. The retrospective study 
assessed the prevalence of  medication non-adherence leading to poor glycemic control. This involved the review of  case 
notes of  one-hundred and fifty two randomly selected patients. Prospective study was done by counselling and educating 
the patients on medication adherence and assessing their medication adherence and the impact of  medication adherence on 
glycemic control. 
Results: The proportions of  females/males with type 2 DM was found to be 69% and 31% respectively. 51.32% of  these 
patients viewed their medications to be unaffordable. 56.6% of  the patient population were 61 years and above in age. There 
was a significant relationship between patient age, gender and adherence to medication. There was however no significant P 
≥ 0.05 association between educational level and adherence. Health education and counselling resulted in adherence rate and 
clinical parameters improvements. 
Conclusion: Non-adherence is a major factor that could lead to morbidity and mortality in diabetic patients. The overall 
improvement in adherence rate of  86.8% was observed with a decline in non- adherence rate after interventions.
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The incidence and prevalence of  diabetes mellitus (DM) 
have continued to increase globally, despite a great deal 
of  research, with the resulting burden resting more 
heavily on tropical, developing countries1-2. Type 2 DM, 
which is the more common of  two basic types of  DM, 
is increasingly being recognized in relatively young per-
sons, due to the high prevalence of  environmental and 
genetic risk factors2.
People living with type 2 DM are more vulnerable to 
varied forms of  both short and long-term complica-
tions, which often lead to their premature death. This 
vulnerability to increased morbidity and mortality is 
seen in patients with type 2 DM because of  the com-
monness of  this type of  DM, its insidious onset and 
late recognition, especially in resource-poor developing 
countries like Nigeria3-4.
It is predicted that prevalence of  DM in adults will in-
crease in the next two decades and much of  the increase 
will occur in developing countries where the majority 
of  patients are aged between 45 and 645-6.
With the current trend of  transition from communica-
ble to non–communicable diseases, it is projected that 
the latter will equal or even exceed the former in de-
veloping nations, thus culminating in double burden7-8. 
Type 2 DM is the most prevalent form of  diabetes mel-
litus and accounts for about 90% of  cases of  diabetes9. 
The WHO 2004 report estimates that 1.7 million peo-
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ple in Nigeria have diabetes, with the projection that the 
number will triple by 20309.
Although hyperglycaemia often presents with few out-
ward symptoms, tight control of  blood glucose is need-
ed to prevent many of  the short- and long-term compli-
cations of  type 2 diabetes. A Blood glucose control goal 
requires active patient participation in order to master a 
complex array of  self-management skills. These include 
modifying dietary choices, implementing exercise re-
gimes, monitoring blood glucose, and adhering to often 
complex medication regimens10-11.  “Adherence means 
the extent to which a person’s behaviour taking medi-
cation and/or executing lifestyle changes, corresponds 
with agreed recommendations from a health care pro-
vider”12. 
One way in which patients will be better able to manage 
their illnesses is by adhering to their medication regi-
mens.  Many patients, especially patients with a chron-
ic illness, experience difficulties in following treatment 
recommendations. Adherence to long-term therapy for 
chronic illnesses averages only 50%12. As a result of  
poor adherence, patients do not receive optimal benefit 
from their drug therapy. Suboptimal treatment can lead 
to increased use of  health care services (acute care and 
hospitalizations), reduction in patient’s quality of  life, 
and increased health care costs (drug costs and medical 
costs)12-14. The reports of  World Health Organization 
have emphasized that “increasing the effectiveness of  
adherence interventions may have a far greater impact 
on the health of  the population than any improvement 
in specific medical treatments”12. 
In view of  the above, this study intends to evaluate the 
impact of  medication adherence on the clinical out-
comes of  type 2 diabetes patients at Alimosho general 
hospital, Igando Lagos State.
Methodology
Study area
The study was carried out in Alimosho general hospi-
tal, Igando, Lagos, Nigeria, a 101 bed secondary public 
health care facility with average hospital attendance at 
the medical clinic of  240 diabetic patients per month. 
Government has a free drug policy for patients aged 
60 years and above for some drugs and patients are ex-
pected to purchase any additional drugs outside the free 
drug scheme.
Study Design
The study was approved by the hospital research/eth-
ics committee and patients’ consents were appropriate-
ly sought. The medication adherence study was both 
descriptive (retrospective) and prospective. The retro-
spective study assessed the prevalence of  medication 
non-adherence leading to poor glycemic control. This 
involved the review of  case notes of  one-hundred and 
fifty two randomly selected patients that satisfied the 
inclusion criteria and with high probability of  being 
available for follow up during the prospective study. 
The retrospective study specifically assessed the fasting 
blood sugar with at least three consecutive visits to the 
medical outpatient clinic between January and July 2012 
and to find out whether or not their glucose level was 
on target – (i.e. fasting glucose of  less than 7.0 mmol/L 
or 126 mg/dL) and the presence or absence of  com-
plications. Prospective study was done by counselling 
and educating the selected patients on medication ad-
herence and subsequently assessing the impact of  med-
ication adherence on glycemic control.
Parameters assessed at baseline and at end of  inter-
vention include: age, gender, presence or absence of  
co-morbid conditions by objective investigation (such 
as hypertension, CHF, and dyslipidaemia), fasting blood 
glucose at first visit, fasting blood glucose after three 
consecutive visits between two and six weeks interval, 
level of  adherence to therapy and patients knowledge 
about diabetes.
Inclusion criteria
• Patients 18 years and above diagnosed with Type 2  
  Diabetes 
• Presence of  co-morbid conditions like Hypertension, 
  CHF, and dyslipidaemia
Exclusion criteria
• Patients with Type 1 Diabetes 
• Patients visiting the health facility for the first time.
• Patients already having cardiovascular complications.
• Patients who could not communicate well with inter
  viewer.
Data analysis
Data generated was analyzed using SPSS 17.0 software. 
Descriptive statistics were used to analyze the primary 
outcome and baseline clinical values, means and stand-
ard deviation for the continuous clinical and demo-
graphic data.
Results
Tables 1 and 2 were adapted from literature15- 17. The 
tables contained values for the diagnosis and assessing 
the risks associated with diabetes.
 
Table 1. Target Levels of Risk Factors in Patients with Diabetes. 
Blood pressure below 130/80 mm Hg 
Low-density lipoprotein cholesterol below 100 mg/dl 
(2.6 mmol/liter) 
Triglycerides below 150 mg/dl (1.7 mmol/liter) 
High-density lipoprotein cholesterol above 40 mg/dl 
(1.1 mmol/liter) 
Glycosylated hemoglobin below 7 percent 
Table 2: Diabetes diagnostic criteria  
Condition 2-hour glucose Fasting glucose HbA1c 
 mmol/l(mg/dl) mmol/l(mg/dl) % 
Normal  <7.8 (<140) <6.1 (<110) <6.0 
Impaired fasting glycaemia <7.8 (<140) ≥ 6.1(≥110) &<7.0(<126) 6.0-6.4 
Impaired glucose tolerance ≥7.8 (≥140) <7.0 (<126) 6.0-6.4 
Diabetes mellitus ≥11.1 (≥200) ≥7.0 (≥126) ≥6.5 
    
 
Condition                                     2-hour glucose Fasting glucose             HbA1c
                                                 mmol/l(mg/dl) mmol/l(mg/dl)              %
Normal                                     <7.8 (<140) <6.1 (<110)                          <6.0
Impaired fasting glycaemia         <7.8 (<140) ≥ 6.1(≥110) &<7.0(<126) 6.0-6.4
Impaired glucose tolerance         ≥7.8 ( 140) <7.0 ( 126)                           6.0-6.4
Diabetes mellitus                      ≥11.1 (≥200)  ≥7.0 (≥126)                           ≥6.5
The analysis of  one hundred and fifty two (152) case 
records of  patients reviewed revealed that females were 
found to make up sixty nine percent (69%) of  the total 
number of  patients. Patients diagnosed with Type 2 di-
abetes mellitus only were found to make up twenty- six 
percent (26%), with the remaining patient population 
having co- morbid conditions. At baseline assessment, 
four percent (4%) of  the patients had micro- vascular 
complications due to poor glycemic control which was 
linked to non-adherence to medications. Eleven per-
cent (11%) of  the patients studied were found to have 
defaulted with their follow-up appointments. Only elev-
en percent (11%) of  these patients had their glycemic 
control on target at baseline assessment (Table 3).
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Table 3: Patients’ Disease Characteristic and Glycemic Control  




No of type 2 diabetes mellitus female patients  105 69 
No of type 2 diabetes mellitus male patients 47 31 
Patients having type 2 diabetes mellitus only (male & 
female) 
39 26 
Patients having type 2 diabetes mellitus plus 





No of patient having Micro vascular complication  
due to poor glycemic control  
Good Glycemic Control 
Type 2 Diabetes Only                                                       6                                                                     














The age distribution of  the 152 Type 2 diabetes patients 
interviewed was evaluated. Majority (45.4%) of  the pa-
tients were found to be between the ages of  61 and 70 
years with 72.4% of  the patients being females. It was 
also observed that most (72.4%) of  the patients were 
married. 36.2% of  the patients had no formal educa-
tion, 37.5% had primary education, 11.8% secondary 
education and 14.5% post-secondary education (Table 
4).
Table 4: Socio-demographic Characteristics of the Patients 
Characteristics: Age (years) and Sex Frequency (n) Percentage (%) 
31 – 40 2  1.3 
41 – 50 23 15.1 
51 – 60  41 27.0 
61 – 70 69  45.4 
>70 17  11.2  
Male    42 27.6 
Female 110 72.4 
Educational Level   
No formal education  55 36.2 
Primary 57 37.5 
Secondary  18  11.8 
Post Secondary education 22  14.5 
Marital Status   
Single  7 4.6 
Married 110   72.4 
Separated  4 2.6 
Divorced  2  1.3 
Widowed  29   19.1 
97 respondents (63.8%) believed type 2 diabetes can 
be controlled using drugs and life style modification. 
30 respondents (19.7%) believed type 2 diabetes can be 
cured permanently. 3 respondents (2.0%) believed they 
can personally control their blood glucose level without 
using drugs while 22 respondents (14.5%) had no idea 
about the disease .
Significant proportions (51.32%) were of  the opinion 
that type 2 diabetes management was not affordable. 
This was followed by 28.29 % who viewed type 2 diabe-
tes as moderately affordable, 17.76 % were of  the view 
that type 2 diabetes was affordable (Table 5).
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Table 5: Assessing Patients view on Diabetes Management 
Patients view: Male n ( % ) Female n (% ) Total n ( % ) 
Affordable 10 (6.58) 17 (11.18) 27 (17.76) 
Moderately Affordable 8 ( 5.26 ) 35( 23.03) 43( 28.29) 
Not Affordable 23 (15.13) 55 ( 36.19) 78( 51.32 )    
Do not know 1 (0.66) 
( 1.97 ) 
4(2.63) 
Total n( % ) 42 (27.63 ) 110 (72.37) 152 ( 100 ) 
    
 
Fifty-two of  the respondents (34.2%) knew all the 
antidiabetic drugs they are taking by name, 64 of  the 
respondents (42.1%) knew only a few drugs they are 
taking by name, 23 of  the respondents (15.1%) knew 
most but not all the drugs by name, 10 of  the respond-
ents (6.6%) knew some of  the drugs by name while 3 
respondents (2.0%) did not know the name of  the dia-
betic drugs they were taking.
Results on Table 6 showed that 105 respondents (69.0%) 
could only buy their drugs in bits due to high cost of  
medication while 47 respondents (31.0 %) could afford 
to buy all their drugs at once. Of  the respondents that 
buy their drugs in bit, 53 respondents (50.5 %) don’t 
wait for the drugs to get finished, 19 respondents (18.1 
%) stay without drugs between 1– 3 days before refill-
ing, and 33 respondents (31.4 %) stay without drugs 
between 4 – 7 days before refilling.
Table 6: Effect of Cost and Number of Drugs on Adherence  
Characteristics                Frequency (n) Percentage (%) 
Drug Purchase Methods    
At once  47   30.9 
In Refills 105   69.1 
Number of Days of Out of 
Stock  
0 day 53 50.05 
1 – 3 days 19 18.1 
4 – 7 days  
No of medication per prescription 
No Response 3 2.0 
2 23 15.1 
3 72 47.4 
4 33 21.7 






Twenty-three respondents (15.1%) take two medica-
tions per day, 72 respondents (47.4%) take three med-
ications per day, 33 respondents (21.7%) take four 
medications per day, 21 respondents (13.8 %) take five 
medications per day, and while 3 respondents (2.0 %) 
could not state the number of  medication they take per 
day. Furthermore, 78 respondents (51.3 %) had never 
used herbal medicine to treat their ailment alongside 
their medications, 53 respondents (34.9 %) agreed that 
they treat diabetes occasionally with herbal remedies, 
while 21 respondents (13.8 %) agreed they always treat 
their ailment with herbal remedies and their medication 
concurrently. 17 respondents (11.2%) are reminded of  
taking their medication by family members, 9 respond-
ents (6.0%) set alarms to remind themselves of  their 
drugs, 78 respondents (51.3%) are reminded of  taking 
their medication by putting it in a conspicuous place, 
37 respondents (24.3%) use their drugs the same time 
of  the day, and 11 (7.2%) are reminded by other undis-
closed ways.
Two respondents (0.9 %) measured their blood glucose 
daily, 29 respondents (19.1%) measured it weekly, 69 re-
spondents (45.4 %) measured it monthly, 7 respondents 
(4.6 %) measured at no regular interval and 45 respond-
ents (29.6 %) had no response. 
Table 7 showed that after intervention only 22% of  pa-
tients had plasma glucose above 7 mmol/L as against 
59% before intervention, 7% had blood pressure above 
130/80 mm/Hg as against 44 % before intervention, 
9% had LDL above 100 mg/dl against 13 % before 
intervention, while 9% had total cholesterol above 130 
mg/dl as against 25 % before intervention.
Table 7:  Patients Characteristics 
Base Line Characteristics          Frequency (n) Percentage (%) 
Fasting plasma Glucose >7mmol/L or 126mg/dl 89 59 
Blood Pressure > 130/80 mmHg 67 44 
LDL > 100mg/dL  36 24 
HDL < 40mg/dl  19 13 
Total cholesterol > 130mg/dl  38 25 
Characteristics After Education & Counselling 
Fasting plasma glucose ≥ 7mmol/L or 126 mg/dl          34   22 
Blood pressure >130/80mmHg          11  7 
LDL > 100mg/dL          14   9 
HDL < 40mg/dl          5   3 




Table 8 results showed a significant P ≤ 0.05 association 
between age, gender and adherence. However, there is 
no significant P ≥ 0.05 association between educational 
level and adherence.
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Discussion
The debilitating effects that usually occur from clinical 
complications of  diabetes mellitus in affected patients 
make it imperative for clinicians and other healthcare 
professionals to ensure adequate glycemic control in a 
bid to reduce or prevent associated morbidity and mor-
tality. Uncontrolled hyperglycemia, which is the clinical 
manifestation of  diabetes, usually results in micro- and 
macro- vascular complications such as retinopathy, ne-
phropathy, neuropathy and associated cardiovascular 
diseases. One factor that contributes to achieving good 
glycemic control is treatment with anti-diabetic medica-
tions as well as strict medication adherence.
The present study has shown that majority of  the pa-
tients visiting the clinic with cases of  type 2 Diabetes 
Mellitus were females. Only 26 % of  these patients 
were diagnosed with diabetes mellitus only, others had 
co- morbid conditions.  According to the data collected 
11 % of  these patients were found to have poor follow 
up visits in the clinic and analysis revealed significant 
(P ≤ 0.05) correlation between sex and adherence to 
medication.
Table 8:  Association between Age, Gender and Adherence  
                    
Total 
 N (%) 
Age (Years) Adherence 
   N (%) 
Non –Adherence 
  N (%) 
    
31 – 40    0 (.0%) 2 (100%) 2 (100%) 
41 – 50 18 (78.3%) 5(21.7%) 23 (100%) 
51 – 60 37 (90.2%) 4 (9.8%) 41 (100%) 
61 – 70 62(89.9%) 7(10.1%) 69(100%) 
>70 15(88.2%) 2(11.8%) 17(100%) 
Total 132 (86.8%) 20 (13.2%) 152 (100%) 
Gender (Years) 
Male 35 (83.3%) 7 (16.7%) 42 (100%) 
Female 97 (88.2%) 13 (11.8%) 110 (100%) 
Total 132 (88.6%) 20 (13.2%) 152 (100%) 
          P ≤ 0.05 
The cost of  medication has been found to be a militat-
ing factor affecting patients’ adherence to their medi-
cations. According to a study carried out by Mojtabai 
& Olfson18, 7% of  patients were unable to adhere to 
their prescription medications due to cost.  The result 
obtained from our study revealed that more than half  
of  the patients (51.32 %) viewed their drugs as being 
unaffordable with the majority of  them being women. 
Women within the locality of  this study are largely un-
employed with most of  them engaging in petty trade. 
There is therefore the possibility of  non- adherence to 
medications since these patients cannot afford most of  
their medications. Also, the vast majority (69.0 %) of  
patients visiting the clinics stated that they buy their 
drugs in bits due to high cost. This, however, could 
warrant missed doses when the medications are not 
obtained early enough. There is also the possibility of  
sub-optimal drug therapy as a result of  brand differenc-
es since the medications could be obtained from differ-
ing sources with unguaranteed bioequivalence.
About 85.5 % of  the patients have no education be-
yond secondary school. This indicates a low level of  
literacy in the studied population. Also, for a country 
like Nigeria, the possibility of  obtaining employment 
that will ensure substantial income with such qualifica-
tions is low. The implication of  the lower income is the 
probable inability to sustain the cost of  medications for 
a chronic ailment like type 2 diabetes mellitus. However, 
besides the possible implication on affordability, there 
was no significant (P ≥ 0.05) relationship between edu-
cational level and adherence.
A high proportion (56.6 %) of  patients in this study 
were 61 years and above. These groups of  patients are 
classified as the senior class citizens or the elderly. Ac-
cording to earlier studies19-20 in the elderly, the frequen-
cy of  the elderly being admitted for non- adherence to 
their prescribed medications is about 19 -45% which 
was found to be higher than the figure obtained in the 
younger population. The results of  this study showed a 
significant (P ≤ 0.05) relationship between ages of  pa-
tients and their adherence to medication. The disparity 
found can be as a result of  the free health scheme for 
the elderly. This scheme makes it possible for elderly 
patients to obtain free drugs (even though in limited 
quantities), which has an overall effect of  enhancing 
medication adherence. It is also important to note that 
the social support system amongst the families in Ni-
geria to take full responsibility for routine medications 
for the elderly is contributory to good medication ad-
herence.
In further assessing the factors that affect glycemic 
control in these patients, the study discovered that pa-
tients who occasionally or always use herbal medication 
alongside with their anti- diabetic medications were 48.7 
%. Herbal medications have been discovered to cause 
interactions with conventional medications; these inter-
actions can either be beneficial or harmful depending 
on the agent implicated. A study of  Rai et al21 showed 
that the use of  herbal medications and glibenclamide 
gave differing effect on glycemic control. Some herbal 
medications were found to have either synergistic ef-
fects or antagonistic effects while others had no evi-
dence of  efficacy. It is therefore important for patients 
to confirm with their healthcare providers on the safety 
of  herbal medications before using it with oral hypogly-
cemic agents. 
According to Barclay et al22, dietary modification is 
required for type 2 diabetes mellitus patients. This in-
cludes diet low in saturated fat, sodium and carbohy-
drate, and high fibre contents. This is because majority 
of  patients with this condition are usually overweight 
and obese. In agreement with the aforementioned, the 
studied patients have adequate knowledge of  dietary 
lifestyle modification to ensure proper glycemic control.
After intervention through health education and coun-
selling, the patients’ clinical outcomes were found to 
have improved significantly. The results of  the study 
also revealed an improvement in the adherence rate to 
86.8 %. This complies with worldwide data of  adher-
ence rate of  36- 93 % in patients with diabetes23. 
Conclusion
Non-adherence is a major factor that could lead to in-
creased morbidity and mortality in diabetic patients. 
Overall improvement in adherence rate of  86.8 % was 
observed with a decline of  non- adherence rate after 
interventions were made. Strategies to be employed 
during intervention that will ensure improvement in 
adherence should be centred on patient related issues, 
medication related issues, prescriber related issues and 
pharmacist related factors.
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